Replies to post #33234 on Revive Therapeutics Ltd (RVVTF)

[Rubberneck2]

Our potential financial gains aside, it would be a tragedy if those roadblocks were standing in the way of the health of millions.

[Hattrick3]

Hey Fellow Longs! I have only posted here a few times, great grounded conversations on this board! There is one thing out there that I believe once the data is released could be a welcomed “surprise”. Our trial participants were nearly all infected with the Delta strain, they were unvaccinated and we know already that in the first 210 the Bucillamine arm was flawless on the original end points of death and hospitalization; there were none. Don’t sleep on the chance that once we unblind the rest of the study albeit 713 is still on the small side that we could see enough statistical power to tell a powerful story with the original endpoints especially when you consider how low the efficacy bar has been set by prior EUA approvals. Just throwing that out there! GLTA

[Classic Warrior]

ok. I see your point now. Revive did not fail the pcr test; they just wanted to use it as a measure, but FDA said to try something else. Then your comment about a vague PR becomes more clear. A strongly worded, yet accurate retelling, could have had an entirely different spin on this event. In the long run, it doesn't matter. The stuff works and we get approved, or I am going to live in Nosnibor's basement.

I hope they don't make Michael Frank ask each person how many tissues they used to stop their runny nose as an endpoint.

ps. Let's get em.